Rapidly dividing cancer cells

"Rapidly dividing cancer cells" is not a specific molecular entity or canonical therapeutic target; rather, it is a descriptive term referring broadly to the population of tumor cells characterized by uncontrolled and accelerated proliferation. Many traditional chemotherapies exploit this hallmark feature by targeting cellular processes required for rapid division—such as DNA replication or mitosis—but these approaches lack specificity for malignant versus normal proliferative tissues[1][3][5]. The underlying molecular drivers in these populations can vary widely between cancers but often involve dysregulation in pathways such as PI3K/AKT/mTOR, MAPK/ERK, JAK/STAT signaling cascades; mutations in oncogenes like RAS; loss-of-function mutations in tumor suppressors like p53; increased telomerase activity; and altered metabolic programming[2][4][6]. Because “rapidly dividing cancer cell” does not refer to one defined protein/receptor/enzyme/transporter/etc., it cannot be considered a canonical drug target under standard nomenclature conventions. There are no universal biomarkers for "rapidly dividing cancer cells" as a class. Targeting all rapidly dividing cells leads to significant toxicity because many normal tissues also divide quickly, with side effects resulting from damage to healthy tissues that also have high rates of cell turnover. Note: The entry "Rapidly dividing cancer cells" is too broad/vague/generic—it describes a phenotype common across many cancers rather than identifying an actionable molecular target. For structured data purposes requiring specificity at the level of gene/protein/receptor/enzyme/etc., this should be flagged as incorrect/incomplete[1][3].

Other names

Rapidly dividing cellsProliferating cancer cellsFast-growing tumor cells

Drugs that interact with rapidly dividing cancer cells typically act by interfering with processes essential for cell division, such as inhibiting DNA synthesis or function (e.g., alkylating agents, antimetabolites) or disrupting mitotic spindle formation (e.g., taxanes, vinca alkaloids).